MPS Ltd
MPS Ltd Q3 FY26 Results & Concall Highlights: Revenue, Margins & Order Book
Q3 FY26 earnings call: what management guided on revenue, margins and order book.
The short version
Unbound's revenues currently have over 60% contribution from North America; future growth will come predominantly from markets outside North America, with North America growing at single digits. MPS aims for 20%-25% year-on-year growth; PBT CAGR of 21% since FY’21. - Target revenue of INR 1500 crores at similar margins within a few years. - Growth driven by a blend of organic and inorganic strategies; acquisitions constitute ~60% of growth plan. - Segment revenue expected to evolve to approx.
From MPS Ltd's Q3 FY26 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- Unbound's revenues currently have over 60% contribution from North America; future growth will come predominantly from markets outside North America, with North America growing at single digits.
- The company aims to double Unbound's revenue over the next few years by expanding into new geographies such as Southeast Asia, the Middle East, Europe, and Australia.
- The global healthcare AI and knowledge management market is projected to grow significantly, with the AI-driven knowledge management subsector expected to expand from $3 billion to $102 billion by 2034 at a 42% CAGR.
- MPS targets an overall growth rate of 20%-25% year-on-year, blending organic and inorganic routes, with acquisitions comprising about 60% of growth strategy.
- The revenue mix is expected to evolve to roughly 40% Research, 40% Education, and 20% Corporate Learning in the coming years.
- New cross-selling opportunities between MPS and Unbound customers are expected to accelerate revenue growth.
Profitability & Margins
See what MPS Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- MPS Limited expects significant capital outflow over the next 6 to 12 months related to current investments and acquisitions.
- The company shows an appetite for growth through acquisitions, with about 60% of its growth strategy relying on inorganic growth.
- Recent acquisitions like Unbound Medicine involve investments planned to grow the business significantly, including geographic expansion.
- MPS raised INR 42 crores of debt for the Unbound Medicine acquisition but remains comfortable with this debt level.
- Capital distribution through dividends or buybacks will continue if there is surplus capital and depending on board decisions, considering expected capital outflows.
- The company is focused on continued strategic investments in AI and technology to enhance product offerings, especially in Unbound, with ongoing AI infrastructure development and integration.
- Discussions on capital redistribution (dividends and buybacks) will continue at the board level in light of shareholder feedback.
Top-ranked in Printing & Publication
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what MPS Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
MPS Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹205 Cr, net profit ₹47 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What MPS Ltd's management said in earlier quarters
Others in Printing & Publication this season
- Dachepalli Publishers Ltd (Q3 FY26)
90% to 95% of the business (textbook sales) occurs in Q4 and Q1 due to academic calendar seasonality. Key concall takeaways from Dachepalli Publishers Ltd's Q3…
- S Chand & Company Ltd (Q3 FY26)
Historically, syllabus changes have resulted in 15%-20% growth over 2-3 years; this time growth is normalized due to gradual implementation. Key concall…
Frequently Asked Questions
What were MPS Ltd Q3 FY26 results?
Unbound's revenues currently have over 60% contribution from North America; future growth will come predominantly from markets outside North America, with North America growing at single digits. MPS aims for 20%-25% year-on-year growth; PBT CAGR of 21% since FY’21. - Target revenue of INR 1500 crores at similar margins within a few years. - Growth driven by a blend of organic and inorganic strategies; acquisitions constitute ~60% of growth plan. - Segment revenue expected to evolve to approx.
What is MPS Ltd share price analysis?
MPS Ltd currently shows a neutral. The stock trades at a P/E of 26.8 with a market cap of ₹4,916 Cr. Investors should review the full earnings analysis for detailed insights.
Is MPS Ltd planning capital expenditure?
MPS Limited expects significant capital outflow over the next 6 to 12 months related to current investments and acquisitions.
Keep MPS Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.